Pharmacogenetics of asthma: where are we now?

Abstract excerpt

Pharmacogenetics adds value with improved clinical markers and increased ability to predict efficacy with greater clarity. This should lead to individualized and simplified dosing, improved efficacy with specific treatment, and enhanced safety. Improved patient response should lead to enhanced patient compliance. Many challenges remain ahead including ethical issues related to patient confidentiality and banking...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Arachidonate 5-Lipoxygenase
• Share to Asthma
• Share to CRF Receptor, Type 1